The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas

Mechanisms for late-onset neutropenia (LON) after rituximab treatment are poorly defined both for non-Hodgkin lymphoma (NHL) and for autoimmune disorders. We performed a case–control analysis of a prospective cohort of 169 evaluable consecutive rituximab-treated NHL patients to assess cytokines invo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesfa, Daniel, Sander, Birgitta, Lindkvist, Henric, Nilsson, Christer, Kimby, Eva, Hägglund, Hans, Wahlin, Björn E., Klimkowska, Monika, Palmblad, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131291/
https://www.ncbi.nlm.nih.gov/pubmed/34003398
http://dx.doi.org/10.1007/s12032-021-01516-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131291/
https://www.ncbi.nlm.nih.gov/pubmed/34003398
http://dx.doi.org/10.1007/s12032-021-01516-8

Ejemplares similares